AddLife stock

ALIF.B · Nasdaq Stockholm · SEK

Compare AddLife
kr 176.60Change from previous close: −0.90%Absolute change: −kr 1.60

Close · November 20, 2026

Price history

−1.67% over the period

1 year: from kr 179.60 (November 20, 2025) to kr 176.60 (November 20, 2026), −1.67%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026kr 176.60
October 30, 2026kr 182.30
September 30, 2026kr 172.00
August 31, 2026kr 167.50
July 31, 2026kr 161.60
June 30, 2026kr 163.40
May 29, 2026kr 148.90
April 30, 2026kr 142.90
March 31, 2026kr 139.50
February 27, 2026kr 154.20
January 30, 2026kr 136.50
December 30, 2025kr 159.10
November 28, 2025kr 189.00
November 20, 2025kr 179.60

At a glance

  • The company

    Supplies instruments, equipment, consumables and reagents for medical care, research, diagnostics and laboratory analysis, plus medical devices for surgery and healthcare

  • Latest results

    Quarter to September 30, 2026 · EPS kr 1.05 (estimate kr 0.87)

TickerLandia's take on AddLife

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 130.20
52-wk highkr 192.80

−8.40% from the 52-week high

Analysts · 3 analysts

Average targetkr 205.75+16.51% vs. price

Buy 2 · Hold 1 · Sell 0

TickerLandia Fingerprint: AddLife

Compared with similar companies: very low financial strength.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

AddLife is priced as in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), AddLife's P/E today is 38.5, in line with the median of its last 10 fiscal years (35.4; between 26.9 and 70.2 from 2016 to 2025). AddLife's P/E (trailing 12 months): 33.5, +33% against the median of a group of 9 similar companies (25.1).

P/E compared with its history

Compared with 9 similar companies

AddLife's metrics compared with similar companies
MetricAddLifePosition in the groupBand
P/E (trailing 12 months)33.5Middle
Forward P/E55.5High
Operating margin8.9%Middle
ROE11.5%Middle
Debt/equity0.86Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: AddLife. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 2.6B

Latest quarter · Q3 2026

Net income

kr 127M

Latest quarter · Q3 2026

Quarterly net margin

4.9%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
kr 21.52B
P/E
33.5
EPS
kr 5.27
Volume
100.14K
Daily trading
€2.83M
Dividend yield
0.85%
Last ex-dividend on May 7, 2026

How AddLife is changing

All results
  • Revenue grew 14.6% a year on average over the last 5 years

  • Shares outstanding up 8.2% in 5 years

  • Revenue has grown for 9 fiscal years in a row

Returns

AddLife returns with dividends

kr 1,000 invested in AddLife 5 years ago, on November 22, 2021, would be worth kr 527 today with dividends reinvested: −47.29% in total, −12.04% per year. On price alone it would be kr 507 (−49.28%).

PeriodAddLifekr 1,000 becomes
1 month−4.64%kr 954
6 months+17.73%kr 1,177
Year to date+11.00%kr 1,110
1 year−0.64%kr 994
3 years+106.42%kr 2,064
5 years−47.29%kr 527
10 years+503.51%kr 6,035

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

AddLife: technical analysis

AddLife is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 54.7% below its all-time closing high (kr 390.00, September 17, 2021).

Trend
Upward
RSI (14 sessions)
44
Between 30 and 70
vs 200-session average
+11.12%

Active signals

  • Close below the low of the previous 20 sessions.

  • The price is moving in an unusually narrow range compared with the last year.

    since November 10, 2026

Support and resistance

Price areas where AddLife has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistancekr 189.20+7.13%2 touches, last on November 5, 2026
  2. Resistancekr 177.30+0.40%3 touches, last on November 3, 2026
  3. Last pricekr 176.60
  4. Supportkr 174.00−1.47%2 touches, last on July 16, 2026
  5. Supportkr 167.78−5.00%4 touches, last on October 8, 2026
  6. Supportkr 154.12−12.73%6 touches, last on September 10, 2026

Volatility and risk

Volatility (60 sessions, annualised)
24.0%
Largest fall in the last year
−28.78%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

AddLife: seasonality

Average monthly price change over 11 years

−0.2%Jan+2.5%Feb−1.9%Mar+10.9%Apr+6.6%May−0.1%Jun+5.0%Jul+3.3%Aug−5.1%Sep+0.2%Oct+5.7%Nov+2.0%Dec

Over the last 11 years, the strongest month for AddLife has been April: +10.93% on average, positive in 9 years out of 11. The weakest has been September: −5.12% on average, positive in 2 years out of 11. November, the current month, has been positive in 6 years out of 10 (+5.70% on average).

Show chart data
MonthAverageMedianPositive years
January−0.19%+2.27%8 of 10
February+2.49%+5.10%6 of 10
March−1.91%−7.30%4 of 10
April+10.93%+8.01%9 of 11
May+6.57%+6.56%10 of 11
June−0.10%+2.33%6 of 11
July+4.98%+9.20%6 of 11
August+3.28%+3.65%8 of 11
September−5.12%−3.24%2 of 11
October+0.20%+2.01%7 of 11
November+5.70%+1.01%6 of 10
December+2.03%+1.95%7 of 10

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

AddLife and its competitors

Laboratory analytical instruments, microscopes, consumables and reagents, together with medical devices for surgery, orthopaedics, endoscopy and wound care, form the core of AddLife's offering. Its Labtech segment serves diagnostics and biomedical research, with products spanning microbiology, clinical chemistry, molecular biology, immunology and veterinary diagnostics, and it also provides training for customers. The Medtech segment covers critical care, ophthalmology, healthcare IT and assistive devices for the elderly and disabled.

Headquarters
Stockholm, Sweden
Employees
2,428
Founded
1906
Chief executive
Fredrik Dalborg
AddLife and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
AddLifeALIF.B$2.11B8.9%33.5+17.73%
Bonesupport HoldingBONEX$2.03B25.5%78.1+25.60%
OttobockOBCK$2.68B18.7%19.0−31.33%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%
Tecan GroupTECN$3.58B4.9%—+64.44%
GerresheimerGXI$1.19B1.6%—+21.95%

Same industry or related industries, similar size. Compare AddLife with its competitors · Full profile